Given the role of the lectin pathway of complement in general, and MBL in particular in tissue damage related to vasculopathy in vitro and in vivo, we sought to determine a potential link between the lectin pathway and the predisposition to and severity of SSc in a well-characterized Australian SSc cohort. This evidence concerns the gene MBL2 and systemic sclerosis.